Predicted impact of intravenous thrombolysis. Another trial is needed

BMJ. 2000 Apr 8;320(7240):1007.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Risk Assessment / methods
  • Stroke / drug therapy*
  • Thrombolytic Therapy / statistics & numerical data*
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator